Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J, de la Cruz J, Cedillo Á, Llamas P, Duarte R, Jiménez-Yuste V, Hernández-Rivas JÁ, Gil-Manso R, Kwon M, Sánchez-Godoy P, Martínez-Barranco P, Colás-Lahuerta B, Herrera P, Benito-Parra L, Alegre A, Velasco A, Matilla A, Aláez-Usón MC, Martos-Martínez R, Martínez-Chamorro C, Susana-Quiroz K, Del Campo JF, de la Fuente A, Herráez R, Pascual A, Gómez E, Pérez-Oteyza J, Ruiz E, Alonso A, González-Medina J, Martín-Buitrago LN, Canales M, González-Gascón I, Vicente-Ayuso MC, Valenciano S, Roa MG, Monteliu PE, López-Jiménez J, Escobar CE, Ortiz-Martín J, Diez-Martin JL, Martinez-Lopez J; Asociación Madrileña de Hematología y Hemoterapia (AMHH). García-Suárez J, et al. Among authors: llamas p. J Hematol Oncol. 2020 Oct 8;13(1):133. doi: 10.1186/s13045-020-00970-7. J Hematol Oncol. 2020. PMID: 33032660 Free PMC article.
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.
Alonso-Dominguez JM, Casado LF, Anguita E, Gomez-Casares MT, Buño I, Ferrer-Marín F, Arenas A, Del Orbe R, Ayala R, Llamas P, Salgado RN, Osorio S, Sanchez-Godoy P, Burgaleta C, Mahíllo-Fernández I, Garcia-Gutierrez V, Steegmann JL, Martinez-Lopez J. Alonso-Dominguez JM, et al. Among authors: llamas p. PLoS One. 2017 Jul 13;12(7):e0181366. doi: 10.1371/journal.pone.0181366. eCollection 2017. PLoS One. 2017. PMID: 28704552 Free PMC article.
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial.
Marcos-Jubilar M, Carmona-Torre F, Vidal R, Ruiz-Artacho P, Filella D, Carbonell C, Jiménez-Yuste V, Schwartz J, Llamas P, Alegre F, Sádaba B, Núñez-Córdoba J, Yuste JR, Fernández-García J, Lecumberri R; BEMICOP Investigators. Marcos-Jubilar M, et al. Among authors: llamas p. Thromb Haemost. 2022 Feb;122(2):295-299. doi: 10.1055/a-1667-7534. Epub 2021 Dec 29. Thromb Haemost. 2022. PMID: 34638151 Free article. Clinical Trial.
Two distinct molecular subtypes of chronic lymphocytic leukemia give new insights on the pathogenesis of the disease and identify novel therapeutic targets.
Cordoba R, Sanchez-Beato M, Herreros B, Domenech E, Garcia-Marco J, Garcia JF, Martinez-Lopez J, Rodriguez A, Garcia-Raso A, Llamas P, Piris MA. Cordoba R, et al. Among authors: llamas p. Leuk Lymphoma. 2016;57(1):134-42. doi: 10.3109/10428194.2015.1034706. Epub 2015 May 12. Leuk Lymphoma. 2016. PMID: 25811675
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.
Fernández-Capitán C, Barba R, Díaz-Pedroche MDC, Sigüenza P, Demelo-Rodriguez P, Siniscalchi C, Pedrajas JM, Farfán-Sedano AI, Olivera PE, Gómez-Cuervo C, Llamas P, Villares P, Sanchez O, López-Reyes R, Catella J, Bikdeli B, Weinberg I, Tafur AJ, Jiménez D, Monreal M. Fernández-Capitán C, et al. Among authors: llamas p. Semin Thromb Hemost. 2021 Jun;47(4):351-361. doi: 10.1055/s-0040-1718402. Epub 2020 Oct 21. Semin Thromb Hemost. 2021. PMID: 33086403 Clinical Trial.
Three monocytic neoplasms in a single patient.
Pérez-Sáenz MA, Rodriguez-Pinilla SM, Salgado RN, Carvajal N, Serrano C, Soto C, Serrano J, Atance M, López-Lorenzo JL, Requena L, Rojo F, Piris MA, Llamas P, Alonso-Dominguez JM. Pérez-Sáenz MA, et al. Among authors: llamas p. Leuk Lymphoma. 2020 Oct;61(10):2523-2526. doi: 10.1080/10428194.2020.1761966. Epub 2020 May 25. Leuk Lymphoma. 2020. PMID: 32449424 No abstract available.
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.
Demelo-Rodriguez P, Farfán-Sedano AI, Pedrajas JM, Llamas P, Sigüenza P, Jaras MJ, Quintana-Diaz M, Fernández-Capitán C, Bikdeli B, Jiménez D, Monreal M; RIETE-BLEEDING Investigators. Demelo-Rodriguez P, et al. Among authors: llamas p. J Thromb Haemost. 2021 Aug;19(8):1981-1989. doi: 10.1111/jth.15400. Epub 2021 Jun 20. J Thromb Haemost. 2021. PMID: 34018658 Free PMC article.
Uveitis and Myositis as Immune Complications in Chemorefractory NK/T-Cell Nasal-Type Lymphoma Successfully Treated with Allogeneic Stem-Cell Transplant.
Gómez-Crespo MJ, García-Raso A, López-Lorenzo JL, Villaescusa T, Rodríguez-Pinilla M, Fortes J, Serrano C, Machan S, Llamas P, Córdoba R. Gómez-Crespo MJ, et al. Among authors: llamas p. Case Rep Hematol. 2016;2016:7297920. doi: 10.1155/2016/7297920. Epub 2016 Oct 11. Case Rep Hematol. 2016. PMID: 27807488 Free PMC article.
145 results